ResearchNew Earnings Calendar Economic Calendar

AI Financial Intelligence
Professional analysis of central bank decisions

Markets

News
Forex
Stocks
Crypto
Gold
Commodities
Indices
ETFs

Analysis

Fed
ECB
COT
Economic Calendar

Learn

Service Guide
MCP Server
Oil

Company

About
Contact
Data Methodology
AI Disclosure
Pricing
Enterprise
Terms
Privacy
Security
WhatsApp

Status data is currently unavailable

The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

We use cookiesPrivacy Policy

AI Financial Intelligence
Professional analysis of central bank decisions

Markets

News
Forex
Stocks
Crypto
Gold
Commodities
Indices
ETFs

Analysis

Fed
ECB
COT
Economic Calendar

Learn

Service Guide
MCP Server
Oil

Company

About
Contact
Data Methodology
AI Disclosure
Pricing
Enterprise
Terms
Privacy
Security
WhatsApp

Status data is currently unavailable

The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

BreakingStocks

Quest Diagnostics Hikes 2026 Guidance After 10% Q3 Revenue Growth

First Detected: Oct 22, 2026, 10:52 AM

Last Update: 1 minute ago

1 update

Event Summary

Quest Diagnostics reported third-quarter revenues of $3.10 billion, marking a 10% increase from the previous year. Following these results, the company raised its full-year 2026 adjusted diluted EPS guidance. The new earnings forecast is now set between $11.25 and $11.35 per share.

Timeline

Latest developmentabout 8 hours ago

Quest Diagnostics Beats Q3 Estimates and Raises Full-Year Profit Outlook

The company delivered adjusted EPS of $3.00, beating estimates by $0.13, while hiking its full-year earnings guidance to a range of $11.25 to $11.35 per share.

Read the full story

Key facts

Quest Diagnostics reported Q3 revenues of $3.10 billion, a 10% increase compared to the previous year.
The company raised its full-year 2026 adjusted diluted EPS guidance to a range of $11.25 to $11.35.